Description
Victoza injection pen is a once-daily GLP-1 receptor agonist that helps manage blood sugar levels in adults with type 2 diabetes. Containing liraglutide, the same active ingredient as Saxenda (used for weight management), Victoza works by stimulating insulin release and reducing appetite, making it beneficial for both glucose control and gradual weight loss.
Key Features:
-
Contains liraglutide, a clinically proven GLP-1 analogue
-
Designed for type 2 diabetes management and weight reduction
-
Administered once daily via a prefilled injection pen
-
Helps regulate insulin and glucose response
-
May lower cardiovascular risk in adults with type 2 diabetes (FDA Study)
How It Works:
Victoza mimics the natural GLP-1 hormone, enhancing the body’s insulin response when blood sugar levels rise and slowing digestion to reduce appetite and food intake.
Usage Instructions:
-
Inject once daily, at any time of day, with or without food
-
Administer subcutaneously (in the abdomen, thigh, or upper arm)
-
Start with 0.6mg daily for one week, then increase gradually as directed
-
Use NovoFine® needles (sold separately)
Victoza Injection Pen Side Effects:
Possible side effects include nausea, vomiting, or mild stomach discomfort. These usually decrease over time. For full safety details, refer to the FDA Victoza Label.
Storage Instructions:
-
Store in a refrigerator (36°F–46°F / 2°C–8°C) before use
-
After first use, can be stored at room temperature (below 86°F / 30°C) for up to 30 days
-
Keep capped and away from sunlight
Reviews
There are no reviews yet.